| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 16 | |
| #2 | Australia | 2 | |
| #3 | Canada | 2 | |
| #4 | China | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | United States | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | Mexico | 1 | |
| #10 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Heterocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Clarke Anthony | 15 |
| #2 | Willis Andrew Gareth | 8 |
| #3 | Stewart Richard Allistair | 8 |
| #4 | Stewart Richard Alistair Balfour | 6 |
| #5 | Anthony Clarke | 3 |
| #6 | Richard Allistair Stewart | 2 |
| #7 | Andrew Gareth Willis | 2 |
| #8 | Stewart Richard Alistaire Balfour | 1 |
| #9 | Richard Alistair Balfour Stewart | 1 |
| Publication | Filing date | Title |
|---|---|---|
| GB201902454D0 | Dosage regimen | |
| AU2018306520A1 | Cytisine salts | |
| GB201713225D0 | Composition | |
| GB201713228D0 | Device | |
| GB201713226D0 | Compositions | |
| GB201713224D0 | Regimen | |
| GB201711899D0 | Salt | |
| GB201711901D0 | Salt | |
| GB201711900D0 | Salt | |
| GB201614228D0 | Device | |
| GB201614232D0 | Regimen | |
| GB201614235D0 | Compounds | |
| GB201614231D0 | Composition | |
| GB201614230D0 | Compositions | |
| GB201602145D0 | Salt |